Pathology of experimental autoimmune uveoretinitis in mice.
The histopathology and immunopathology of murine experimental autoimmune uveoretinitis (EAU) following active immunization with the interphotoreceptor retinoid-binding protein (IRBP) were studied. The methods used included conventional light microscopy and immunoperoxidase staining. Lesions were located mainly in the uvea and the retina and were characteristically focal. The prominent histopathologic findings in the retina were vasculitis, granuloma, retinal fold, focal serous detachment, and loss of photoreceptors. Granulomas, formation of Dalen-Fuchs nodules, inflammatory cellular infiltration and increase in the thickness of the choroid and ciliary body were frequent findings. Subretinal neovascularization occurred in 10% of the experimental animals. Mild to moderate inflammation was also noted in the vitreous. The predominant infiltrating cells in the retinal and uveal granuloma and the Dalen-Fuchs nodules were macrophages. In contrast, the predominant infiltrating cell types in the vitreous were T helper/inducer lymphocytes. T suppressor/cytotoxic cells were rarely seen. Expression of Ia antigens on the ocular cells was confined to the immediate area of the inflammatory sites. The kinetics of histopathology showed two peaks at the 5th and 10th week after immunization, suggesting a relapsing course of the disease.
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892.
C C
CC
Chan
R R
RR
Caspi
M
M
Ni
W C
WC
Leake
B
B
Wiggert
G J
GJ
Chader
R B
RB
Nussenblatt
D000818:Animals; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000276:immunology / Q000473:pathology*; D005136:Eye Proteins; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis; D007114:Immunization; D007249:Inflammation / Q000276:immunology; D007700:Kinetics; D008264:Macrophages; D051379:Mice; D015861:Retinal Neovascularization / Q000276:immunology / Q000473:pathology; D012173:Retinitis / Q000139:chemically induced / Q000276:immunology / Q000473:pathology*; D012177:Retinol-Binding Proteins / Q000008:administration & dosage* / Q000276:immunology; D014822:Vitreous Body / Q000276:immunology / Q000473:pathology; D000099214:Retinol-Binding Proteins, Interstitial
D005136:Eye Proteins; D000949:Histocompatibility Antigens Class II; D012177:Retinol-Binding Proteins; D000099214:Retinol-Binding Proteins, Interstitial